玻璃体内注射贝伐单抗治疗视网膜中央静脉阻塞所致黄斑水肿的注射方案：一项多中心研究的结果 - Suppr

Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study.

作者信息

Januschowski Kai, Dimopoulos Spyridon, Szurman Peter, Feltgen Nicolas, Spitzer Bernhard, Pielen Amelie, Rehak Matus, Spital Georg, Meyer Carsten H, Szurman Gesine B

机构信息

Centre for Ophthalmology, University Eye Clinic Tuebingen, Tuebingen, Germany.

Knappschaftsaugenklinik, Sulzbach-Saar, Germany.

出版信息

Acta Ophthalmol. 2015 Aug;93(5):e400-e402. doi: 10.1111/aos.12600. Epub 2015 Jan 25.

DOI:10.1111/aos.12600

PMID:25619682

Abstract

摘要

相似文献

Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study.玻璃体内注射贝伐单抗治疗视网膜中央静脉阻塞所致黄斑水肿的注射方案：一项多中心研究的结果

Acta Ophthalmol. 2015 Aug;93(5):e400-e402. doi: 10.1111/aos.12600. Epub 2015 Jan 25.

"Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.玻璃体内注射贝伐单抗在视网膜静脉阻塞继发的非缺血性黄斑水肿中的“超说明书”使用。

Rom J Ophthalmol. 2016 Apr-Jun;60(2):90-95.

Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicentre study.玻璃体内注射贝伐单抗治疗视网膜中央静脉阻塞所致黄斑水肿的注射方案：一项多中心研究的结果

Acta Ophthalmol. 2017 May;95(3):e245-e246. doi: 10.1111/aos.12976. Epub 2016 Feb 1.

Comparison of immediate versus deferred intravitreal Bevacizumab in macular oedema due to branch retinal vein occlusion: a pilot study.黄斑区视网膜分支静脉阻塞所致黄斑水肿中玻璃体内注射贝伐单抗即刻给药与延迟给药的比较：一项初步研究

Int Ophthalmol. 2018 Jun;38(3):943-949. doi: 10.1007/s10792-017-0538-y. Epub 2017 Apr 21.

Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.玻璃体内注射贝伐单抗治疗视网膜分支静脉阻塞后黄斑水肿的疗效，按基线视力分层分析

Graefes Arch Clin Exp Ophthalmol. 2017 Apr;255(4):691-697. doi: 10.1007/s00417-016-3535-3. Epub 2016 Oct 29.

EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.阿柏西普与雷珠单抗治疗视网膜中央静脉阻塞继发黄斑水肿的疗效及频率。

Retina. 2018 Sep;38(9):1795-1800. doi: 10.1097/IAE.0000000000001782.

Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.抗血管内皮生长因子治疗视网膜分支静脉阻塞继发的黄斑水肿

Cochrane Database Syst Rev. 2020 Jul 7;7(7):CD009510. doi: 10.1002/14651858.CD009510.pub3.

Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab.玻璃体内注射贝伐单抗后与分支视网膜静脉阻塞相关的黄斑水肿复发。

Jpn J Ophthalmol. 2012 Mar;56(2):165-74. doi: 10.1007/s10384-011-0113-4. Epub 2011 Dec 20.

Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.两种剂量玻璃体内注射贝伐单抗作为视网膜中央静脉阻塞继发黄斑水肿的一线治疗：泛美合作视网膜研究组 24 个月的结果。

Retina. 2010 Jul-Aug;30(7):1002-11. doi: 10.1097/IAE.0b013e3181cea68d.

Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.玻璃体内注射贝伐单抗治疗视网膜静脉阻塞继发黄斑水肿后对视网膜中央的临床、解剖学及电生理评估

Int Ophthalmol. 2016 Feb;36(1):21-36. doi: 10.1007/s10792-015-0066-6. Epub 2015 Mar 29.

引用本文的文献

Risk Factors and Treatment Strategy for Retinal Vascular Occlusive Diseases.视网膜血管阻塞性疾病的危险因素及治疗策略

J Clin Med. 2022 Oct 27;11(21):6340. doi: 10.3390/jcm11216340.

Individualized treat-and-extend regime for optimization of real-world vision outcome and improved patients' persistence.个体化治疗-延长方案，优化真实世界的视力结局，提高患者的依从性。

BMC Ophthalmol. 2020 Mar 30;20(1):122. doi: 10.1186/s12886-020-01397-x.

Hydrofluoric Acid and Other Impurities in Toxic Perfluorooctane Batches.有毒全氟辛烷批次中的氢氟酸和其他杂质。

Transl Vis Sci Technol. 2019 May 29;8(3):24. doi: 10.1167/tvst.8.3.24. eCollection 2019 May.

Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion.视网膜中央静脉阻塞后玻璃体内注射贝伐单抗后功能改善的预测因素。

Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):1045-1046. doi: 10.1007/s00417-017-3618-9. Epub 2017 Feb 21.

Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):457-462. doi: 10.1007/s00417-016-3471-2. Epub 2016 Sep 8.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study.

作者信息

Januschowski Kai, Dimopoulos Spyridon, Szurman Peter, Feltgen Nicolas, Spitzer Bernhard, Pielen Amelie, Rehak Matus, Spital Georg, Meyer Carsten H, Szurman Gesine B

机构信息

Centre for Ophthalmology, University Eye Clinic Tuebingen, Tuebingen, Germany.

Knappschaftsaugenklinik, Sulzbach-Saar, Germany.

出版信息

Acta Ophthalmol. 2015 Aug;93(5):e400-e402. doi: 10.1111/aos.12600. Epub 2015 Jan 25.

DOI:10.1111/aos.12600

PMID:25619682

Abstract

摘要

Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献